When it is just in the first phases of commercialisation and is involved in a large R&D program there is nothing wrong with this kind of result.
I am wondering when we get to see a 1,000% annual increase in revenue - i.e. The base is too low / timing is too early to make meaningful percentage comparisons. Ideally we need to see a 10,000% increase in revenue over the next 5 years.
News: Pharmaxis reports 13% loss , page-3
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
-0.003(8.82%) |
Mkt cap ! $40.00M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.3¢ | 3.1¢ | $81.20K | 2.512M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 652531 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 812778 | 3 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| SNT (ASX) Chart |